Splanchnic vein thrombosis in patients with COVID-19 infection

This study is an investigator-initiated study examining the prevalence, clinical presentation and outcome of splanchnic vein thrombosis in patients with a COVID-19 infection.

This study is endorsed by the BASL steering committee and is also endorsed by the vascular liver disease group (VALDIG) and is thus just starting at an European level too.

If you have any cases in your hospital and are interested in this study, please contact the Belgian coordinator (Prof. Pierre Deltenre) for further information